HQY — HealthEquity, Inc.

HealthEquity (HQY) Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Increased 7% year-over-year to $282.2 million.
• Net Income: Up 806% year-over-year to $51.7 million ($0.59 per share), significantly influenced by a $30 million legal settlement in the prior year.
• Non-GAAP Net Income: Increased 26% to $87.7 million ($1.01 per share).
• Adjusted EBITDA: Rose 20% to $141.8 million, with a margin of 44%.
• HSA Accounts: Grew to over 10 million, with total accounts reaching 17 million.
• HSA Assets: Increased 15% year-over-year to over $34 billion.
• Gross Margin: Improved to 71%, up from 66% in the prior year.

2. Strategic Updates and Business Highlights

• Growth Initiatives: HealthEquity launched a new direct HSA enrollment platform aimed at individuals choosing Bronze plans on ACA exchanges, enhancing accessibility.
• Marketplace Expansion: Early momentum observed in the HealthEquity Marketplace, including offerings for weight loss programs, which are expected to drive member engagement and spending.
• AI Investments: Ongoing deployment of AI technologies to enhance customer service and operational efficiency.
• Security Enhancements: Continued investments in fraud prevention resulted in fraud costs significantly below targets.
• Legislative Advocacy: Active engagement in Washington to promote HSA expansion and accessibility, with a focus on affordability challenges in healthcare.

3. Forward Guidance and Outlook

• Fiscal 2026 Revenue Guidance: Expected to be between $1.302 billion and $1.312 billion.
• GAAP Net Income Guidance: Projected between $197 million and $205 million ($2.24 to $2.33 per share).
• Non-GAAP Net Income Guidance: Estimated between $341 million and $348 million ($3.87 to $3.95 per share).
• Adjusted EBITDA Guidance: Anticipated between $555 million and $565 million.
• Continued Share Repurchases: Approximately $259 million remaining under the repurchase authorization.

4. Bad News, Challenges, or Points of Concern

• Market Challenges: Concerns about a slowdown in the HSA market and the impact of macroeconomic conditions on new account growth.
• Competitive Pressures: Potential pricing pressures in the high end of the market as competition intensifies, particularly among smaller employers and new exchange-based accounts.
• Soft Labor Market: Ongoing uncertainty regarding job growth could affect the acquisition of new members, particularly those with lower initial balances.

5. Notable Q&A Insights

• Direct HSA Enrollment: Marketing strategies for the new enrollment platform include partnerships with integrated plan partners and a focus on brand awareness.
• AI and Automation Impact: AI is expected to enhance efficiency across member services, client services, and back-office operations, with significant potential for cost reduction.
• Market Dynamics: Conversations with employer sponsors indicate a growing recognition of HSAs as a solution to rising healthcare costs, with expectations of increased adoption in 2026.
• TAM Expansion: The potential for significant growth in HSA accounts from individuals enrolled in Bronze plans, with estimates suggesting up to 1.6 million new accounts could emerge from the current open enrollment cycle.

Overall, HealthEquity reported strong financial performance in Q3 2026, driven by strategic initiatives aimed at enhancing member engagement and expanding market presence, while navigating challenges related to market competition and macroeconomic conditions.